Nicotine & cancer
This article was originally published in The Tan Sheet
Executive Summary
Transdermal and oral exposure to nicotine could contribute to cancer, researchers state in the January Journal of Clinical Investigation. Phillip Dennis, NCI, et al., find "sustained exposure to nicotine might alter the phenotype of endothelial and/or epithelial cells in undetectable, premalignant lesions," suggesting long-term exposure to smoking cessation drugs such as patches, gum could be harmful. NRT marketers Pharmacia, GSK point to lack of clinical evidence drugs cause cancer. "Tobacco dependence experts agree that the risks of developing cancer from short-term NRT use to aid smoking cessation are insignificant compared to the risks of developing cancer from cigarette smoking," Pharmacia states...
You may also be interested in...
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.